Trial Outcomes & Findings for Rural Interventions for Screening Effectiveness (NCT NCT02795104)

NCT ID: NCT02795104

Last Updated: 2023-10-02

Results Overview

Will be tested initially with pair-wise chi-square tests. Binary logistic regression analysis will be used to compare the two interventions and the UC group on the binary dependent variable (adherence), while adjusting for any potentially confounding covariates. The models will be controlled for any demographic covariate (e.g., age, education) for which the randomized groups differ significantly at baseline using a liberal significance level of 0.20 to achieve conservative adjustment. As a sensitivity analysis, multiple imputation will be used to impute the adherence outcome for participants.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

985 participants

Primary outcome timeframe

Up to 12 months

Results posted on

2023-10-02

Participant Flow

Participant milestones

Participant milestones
Measure
Arm I Tailored and Interactive Digital Versatile Disc (DVD) (TIDVD)
TIDVD: In this arm of the intervention participants watch a tailored interactive DVD program and answer questions posed by the DVD program.
Arm II TIDVD and Patient Navigation (PN) (TIDVD, PN)
TIDVD,PN: In this arm of the educational intervention the participant receives a tailored interactive DVD to watch and telephone calls from a patient navigator
Arm III Usual Care (UC)
UC: In this arm of the intervention participants receive brochures that explain and provide information and encouragement for cancer screening.
Overall Study
STARTED
389
395
201
Overall Study
COMPLETED
382
388
193
Overall Study
NOT COMPLETED
7
7
8

Reasons for withdrawal

Reasons for withdrawal
Measure
Arm I Tailored and Interactive Digital Versatile Disc (DVD) (TIDVD)
TIDVD: In this arm of the intervention participants watch a tailored interactive DVD program and answer questions posed by the DVD program.
Arm II TIDVD and Patient Navigation (PN) (TIDVD, PN)
TIDVD,PN: In this arm of the educational intervention the participant receives a tailored interactive DVD to watch and telephone calls from a patient navigator
Arm III Usual Care (UC)
UC: In this arm of the intervention participants receive brochures that explain and provide information and encouragement for cancer screening.
Overall Study
Determined to be Ineligible with Exit Data
7
5
7
Overall Study
Withdrawal by Subject
0
2
0
Overall Study
Lost to Follow-up
0
0
1

Baseline Characteristics

Nineteen participants (7 TIDVD, 5 TIDVD,PN, 7 UC) who enrolled and participated in the program were determined to be ineligible through additional cancer screening information obtained via exit medical record review. Two participants in the TIDVD,PN Arm withdrew and asked that their data not be used. Exit medical record data was unable to be obtained for one Usual Care participant. These 22 were excluded from analyses.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
ARM I (TIDVD)
n=382 Participants
Educational Intervention via DVD: In this arm of the intervention participants watch a tailored interactive DVD program and answer questions posed by the DVD program. Educational Intervention via DVD: Educational Intervention via DVD: In this arm of the educational intervention the participant receive a tailored interactive DVD to watch
ARM II (TIDVD, PN)
n=388 Participants
Educational Intervention-DVD \& Telephone based Navigation: In this arm of the intervention participants watch a TIDVD and are called by a patient navigator. Educational Intervention-DVD \& Telephone Based Navigation: Educational Intervention via Telephone-Based Navigation: In this arm of the educational intervention the participant receives a tailored interactive DVD to watch and telephone calls from a patient navigator
ARM III (UC)
n=193 Participants
Educational Intervention via brochure: In this arm of the intervention participants receive brochures that explain and provide information and encouragement for cancer screening. Educational Intervention via brochure: Educational Intervention via brochure: In this arm of the educational intervention the participant receives brochures
Total
n=963 Participants
Total of all reporting groups
Age, Customized
Age at consent
58.2 years
STANDARD_DEVIATION 6.4 • n=5 Participants • Nineteen participants (7 TIDVD, 5 TIDVD,PN, 7 UC) who enrolled and participated in the program were determined to be ineligible through additional cancer screening information obtained via exit medical record review. Two participants in the TIDVD,PN Arm withdrew and asked that their data not be used. Exit medical record data was unable to be obtained for one Usual Care participant. These 22 were excluded from analyses.
58.8 years
STANDARD_DEVIATION 6.3 • n=7 Participants • Nineteen participants (7 TIDVD, 5 TIDVD,PN, 7 UC) who enrolled and participated in the program were determined to be ineligible through additional cancer screening information obtained via exit medical record review. Two participants in the TIDVD,PN Arm withdrew and asked that their data not be used. Exit medical record data was unable to be obtained for one Usual Care participant. These 22 were excluded from analyses.
58.8 years
STANDARD_DEVIATION 6.3 • n=5 Participants • Nineteen participants (7 TIDVD, 5 TIDVD,PN, 7 UC) who enrolled and participated in the program were determined to be ineligible through additional cancer screening information obtained via exit medical record review. Two participants in the TIDVD,PN Arm withdrew and asked that their data not be used. Exit medical record data was unable to be obtained for one Usual Care participant. These 22 were excluded from analyses.
58.6 years
STANDARD_DEVIATION 6.3 • n=4 Participants • Nineteen participants (7 TIDVD, 5 TIDVD,PN, 7 UC) who enrolled and participated in the program were determined to be ineligible through additional cancer screening information obtained via exit medical record review. Two participants in the TIDVD,PN Arm withdrew and asked that their data not be used. Exit medical record data was unable to be obtained for one Usual Care participant. These 22 were excluded from analyses.
Sex/Gender, Customized
Female
382 Participants
n=5 Participants
388 Participants
n=7 Participants
193 Participants
n=5 Participants
963 Participants
n=4 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
n=5 Participants
1 Participants
n=7 Participants
3 Participants
n=5 Participants
5 Participants
n=4 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
2 Participants
n=4 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=5 Participants
2 Participants
n=7 Participants
0 Participants
n=5 Participants
3 Participants
n=4 Participants
Race (NIH/OMB)
White
376 Participants
n=5 Participants
375 Participants
n=7 Participants
185 Participants
n=5 Participants
936 Participants
n=4 Participants
Race (NIH/OMB)
More than one race
3 Participants
n=5 Participants
6 Participants
n=7 Participants
3 Participants
n=5 Participants
12 Participants
n=4 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
n=5 Participants
3 Participants
n=7 Participants
1 Participants
n=5 Participants
5 Participants
n=4 Participants
Region of Enrollment
United States · Indiana
159 Participants
n=5 Participants
149 Participants
n=7 Participants
70 Participants
n=5 Participants
378 Participants
n=4 Participants
Region of Enrollment
United States · Ohio
223 Participants
n=5 Participants
239 Participants
n=7 Participants
123 Participants
n=5 Participants
585 Participants
n=4 Participants

PRIMARY outcome

Timeframe: Up to 12 months

Will be tested initially with pair-wise chi-square tests. Binary logistic regression analysis will be used to compare the two interventions and the UC group on the binary dependent variable (adherence), while adjusting for any potentially confounding covariates. The models will be controlled for any demographic covariate (e.g., age, education) for which the randomized groups differ significantly at baseline using a liberal significance level of 0.20 to achieve conservative adjustment. As a sensitivity analysis, multiple imputation will be used to impute the adherence outcome for participants.

Outcome measures

Outcome measures
Measure
Arm I (TIDVD)
n=382 Participants
Educational Intervention via DVD: In this arm of the intervention participants watch a tailored interactive DVD program and answer questions posed by the DVD program. Educational Intervention via DVD: Educational Intervention via DVD: In this arm of the educational intervention the participant receive a tailored interactive DVD to watch
Arm II (TIDVD, PN)
n=388 Participants
Educational Intervention-DVD \& Telephone based Navigation: In this arm of the intervention participants watch a TIDVD and are called by a patient navigator. Educational Intervention-DVD \& Telephone Based Navigation: Educational Intervention via Telephone-Based Navigation: In this arm of the educational intervention the participant receives a tailored interactive DVD to watch and telephone calls from a patient navigator
Arm III (UC)
n=193 Participants
Educational Intervention via brochure: In this arm of the intervention participants receive brochures that explain and provide information and encouragement for cancer screening. Educational Intervention via brochure: Educational Intervention via brochure: In this arm of the educational intervention the participant receives brochures
Percentage of Participants Who Received All Needed Screening and Any Needed Screening Across the Three Randomized Arms
Received All Needed Screenings within 12-months of Enrollment
57 Participants
118 Participants
19 Participants
Percentage of Participants Who Received All Needed Screening and Any Needed Screening Across the Three Randomized Arms
Received Any Needed Screening within 12-months of Enrollment
110 Participants
189 Participants
48 Participants

SECONDARY outcome

Timeframe: Up to 12 months

Population: Same as main outcome. All participants included.

Cost-effectiveness analysis (CEA) implies a comparison of whether the cost per unit of outcome in one situation exceeds that in another. Unless the outcome measures are comparable, this is not possible. Will be able to examine outcomes of the interventions and the UC group (participants who up to date with all three cancer screening guidelines at 12 month follow-up). CEA will consist of measuring the incremental cost of achieving the observed incremental outcomes, but not a cost-effectiveness ratio in standard terms.

Outcome measures

Outcome measures
Measure
Arm I (TIDVD)
n=382 Participants
Educational Intervention via DVD: In this arm of the intervention participants watch a tailored interactive DVD program and answer questions posed by the DVD program. Educational Intervention via DVD: Educational Intervention via DVD: In this arm of the educational intervention the participant receive a tailored interactive DVD to watch
Arm II (TIDVD, PN)
n=388 Participants
Educational Intervention-DVD \& Telephone based Navigation: In this arm of the intervention participants watch a TIDVD and are called by a patient navigator. Educational Intervention-DVD \& Telephone Based Navigation: Educational Intervention via Telephone-Based Navigation: In this arm of the educational intervention the participant receives a tailored interactive DVD to watch and telephone calls from a patient navigator
Arm III (UC)
n=193 Participants
Educational Intervention via brochure: In this arm of the intervention participants receive brochures that explain and provide information and encouragement for cancer screening. Educational Intervention via brochure: Educational Intervention via brochure: In this arm of the educational intervention the participant receives brochures
Cost Effectiveness of Each Intervention
14,462.64 USD ('22) per completed UTD screening
10,638.20 USD ('22) per completed UTD screening
0 USD ('22) per completed UTD screening

SECONDARY outcome

Timeframe: Up to 12 months

Population: Same as main outcome. All participants of study.

In the model implemented in this study, the patient navigators spend full time in that activity. Thus, the costs of implementation are straightforward and obtainable. Even though the navigator is full-time, data were collected concerning broad categories of time use through a structured time log so that the cost of specific components (e.g., arranging transportation) can be estimated more accurately. A developed Participant Encounter Form and a Tracking Log of Direct Participant Contacts were used to provide the majority of this information.

Outcome measures

Outcome measures
Measure
Arm I (TIDVD)
n=382 Participants
Educational Intervention via DVD: In this arm of the intervention participants watch a tailored interactive DVD program and answer questions posed by the DVD program. Educational Intervention via DVD: Educational Intervention via DVD: In this arm of the educational intervention the participant receive a tailored interactive DVD to watch
Arm II (TIDVD, PN)
n=388 Participants
Educational Intervention-DVD \& Telephone based Navigation: In this arm of the intervention participants watch a TIDVD and are called by a patient navigator. Educational Intervention-DVD \& Telephone Based Navigation: Educational Intervention via Telephone-Based Navigation: In this arm of the educational intervention the participant receives a tailored interactive DVD to watch and telephone calls from a patient navigator
Arm III (UC)
n=193 Participants
Educational Intervention via brochure: In this arm of the intervention participants receive brochures that explain and provide information and encouragement for cancer screening. Educational Intervention via brochure: Educational Intervention via brochure: In this arm of the educational intervention the participant receives brochures
Cost of the Interventions
326,012.29 US Dollars (2022)
670,841.46 US Dollars (2022)
0 US Dollars (2022)

Adverse Events

Arm I Tailored and Interactive Digital Versatile Disc (DVD) (TIDVD)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Arm II TIDVD and Patient Navigation (PN) (TIDVD, PN)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Arm III Usual Care (UC)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Ryan Baltic

The Ohio State University Comprehensive Cancer Center

Phone: 614-293-4121

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place